S. K. R. Korea

Coronary Heart Disease Phospholipase a 2 Enzymes, High-dose Atorvastatin, and Prediction of Ischemic Events after Acute Coronary Syndromes for the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (miracl) Trial Investigators Clinical Perspective on P 766 Laboratory and Oxidative Bi

A. Tedgui, Z. Mallat, S. Tsimikas, 2022 .